Publications by authors named "Wonjoon Jang"
Background: Approximately half of the patients with advanced pancreatic ductal adenocarcinoma (PDAC) receive subsequent lines of chemotherapy. Recently, the liposomal irinotecan (nal-IRI) plus 5-fluorouracil/leucovorin (5-FU/LV) regimen is recommended as subsequent lines of chemotherapy. However, little is known about the predictive factors for the nal-IRI + 5-FU/LV regimen, especially in patients with previous irinotecan (IRI) exposure.
View Article and Find Full Text PDFArticle Synopsis
- The study examined the characteristics and prognosis of Korean patients with hepatocellular carcinoma (HCC) based on the disease's etiology, focusing on data from 2010-2014.
- Out of 1,595 patients analyzed, those with hepatitis B had the best survival rates, followed by hepatitis C, while non-B non-C patients faced significantly poorer outcomes.
- The research highlighted that the presence of diabetes mellitus negatively impacted survival rates, particularly in patients with early-stage HCC.